ArticleKidney international reports2022

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria.

Jonathan Barratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.